Series C funding round for Intercept Pharmaceuticals raising $30M in August 2012
Series C funding round for Intercept Pharmaceuticals raising $30M in August 2012
| Investor | Firm Type | Partner |
|---|
OrbiMedLEAD | Venture Capital | — |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$55M
Top Valuation
-
Intercept Pharmaceuticals raised $30M in a Series C round.
The round was announced on 08/01/12.
The round was led by OrbiMed.